raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:28378

Tyrosinemia type 2

Synonyms: Keratosis palmoplantaris-corneal dystrophy syndrome · Oculocutaneous tyrosinemia · Richner-Hanhart syndrome · Tyrosinemia due to TAT deficiency · Tyrosinemia due to tyrosine aminotransferase deficiency · Tyrosinemia type II

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Childhood, Infancy, Neonatal
Status
active

A rare inborn error of tyrosine metabolism characterized by hypertyrosinemia with oculocutaneous manifestations and, in some cases, intellectual deficit.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enTyrosinemia type 2Keratosis palmoplantaris-corneal dystrophy syndrome · Oculocutaneous tyrosinemia · Richner-Hanhart syndrome · Tyrosinemia due to TAT deficiency · Tyrosinemia due to tyrosine aminotransferase deficiency · Tyrosinemia type II
frTyrosinémie type 2Syndrome de Richner-Hanhart · Syndrome de kératose palmoplantaire-dystrophie cornéenne · Tyrosinémie oculocutanée · Tyrosinémie par déficit en TAT · Tyrosinémie par déficit en tyrosine aminotransférase · Tyrosinémie type II
deTyrosinämie Typ 2Tyrosinämie durch TAT-Mangel · Tyrosinämie durch Tyrosintransaminase-Mangel · Okulokutane Tyrosinämie · Palmoplantarkeratose - Hornhautdystrophie · Richner-Hanhart-Syndrom · Tyrosinämie Typ II
esTirosinemia tipo 2Queratosis palmoplantar-distrofia corneal · Síndrome de Richner-Hanhart · Tirosinemia oculocutánea · Tirosinemia por deficiencia de TAT · Tirosinemia por deficiencia de tirosina aminotransferasa · Tirosinemia tipo II
itTirosinemia, tipo 2Cheratosi palmoplantare - distrofia corneale · Sindrome di Richner-Hanhart · Tirosinemia da deficit di TAT · Tirosinemia da deficit di tirosina aminotransferasi · Tirosinemia oculocutanea · Tirosinemia, tipo II
nlTyrosinemie type 2Keratosis palmoplantaris - hoornvliesdystrofie-syndroom · Oculocutane tyrosinemie · Syndroom van Richner-Hanhart · Tyrosinemie als gevolg van TAT-deficiëntie · Tyrosinemie als gevolg van tyrosine aminotransferasedeficiëntie · Tyrosinemie type II
ptTirosinemia tipo 2Tirosinemia por deficiência de TAT · Tirosinemia por deficiência de tirosina aminotransferase · Tirosinemia tipo II · Síndrome Richner-Hanhart · Síndrome de queratose palmo-plantar-distrofia da córnea · Tirosinemia oculo-cutânea
plTyrozynemia typu 2Rogowiec dłoniowo-podeszwowy - dystrofia rogówki · Tyrozynemia oczno-skórna · Tyrozynemia spowodowana niedoborem aminotransferazy tyrozyny · Tyrozynemia spowodowana niedoborem TAT · Tyrozynemia typu II · Zespół Richnera i Hanharta
csTyrosinémie, typ 2Syndrom zahrnující keratosis palmoplantaris a korneální dystrofii · Okulokutánní tyrosinémie · Tyrosinémie, typ II · Richnerův-Hanhartův syndrom · Tyrosinémie způsobená deficitem TAT · Tyrosinémie způsobená deficitem tyrosin aminotransferázy · Richner-Hanhartův syndrom
ukТирозинемія, тип 2Синдром кератозу пальмоплантарно-рогівкової дистрофії · Окулярна тирозинемія · Синдром Ріхнера-Ганхарта · Тирозинемія внаслідок дефіциту ТАТ · Тирозинемія внаслідок дефіциту тирозин-амінотрансферази · Тирозинемія II типу
zh酪氨酸血症II型酪氨酸氨基转移酶缺乏所致酪氨酸血症
trTirozinemi tip 2Tirozinemi tip II · Richner-Hanhart sendromu · Okülokütan tirozinemi · TAT eksikliğine bağlı tirozinemi · Keratoz palmoplantaris-korneal distrofi sendromu · Tirozin aminotransferaz eksikliğine bağlı tirozinemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM276600Evalidated
ICD-10E70.2NTBTinclusionvalidated
ICD-115C50.12Especificvalidated
MONDO0010160Evalidated
UMLSC0268487Evalidated
GARD3105Evalidated
MedDRA10069463Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TATDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:11573ENSG0000019865061301816q22.2tyrosine aminotransferase1357662[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families150 casesWorldwideCase(s)Validated8912606[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2018-01-18
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0007957Corneal opacity
HP:0000962Hyperkeratosis
HP:0001249Intellectual disability
HP:0000982Palmoplantar keratoderma
Frequent (79-30%)
HP:0004337Abnormality of amino acid metabolism
HP:0000708Atypical behavior
HP:0000975Hyperhidrosis
HP:0000639Nystagmus
HP:0000613Photophobia
Occasional (29-5%)
HP:0001597Abnormal nail morphology
HP:0002167Abnormality of speech or vocalization
HP:0001251Ataxia
HP:0000272Malar flattening
HP:0000252Microcephaly
HP:0001250Seizure
HP:0001337Tremor
HP:0000572Visual loss

Run the differential on the 4 obligate / very frequent terms

7

Sources for this card